Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II studyRui‐Hua Xu, Lin Shen, Hongming Pan et al.|BMC Cancer|2017Cited by 15
A phase II study of Chinese patients (pts) treated with <i>nab</i>-paclitaxel (<i>nab</i>-P) plus gemcitabine (Gem) for metastatic pancreatic cancer (MPC).Lin Shen, Rui‐Hua Xu, Xianjun Yu et al.|Journal of Clinical Oncology|2016Cited by 2